Journal of International Oncology››2014,Vol. 41››Issue (2): 124-126.doi:10.3760/cma.j.issn.1673-422X.2014.02.014
Previous ArticlesNext Articles
Li Ruijian, Yu Liang
Received:
2013-09-16Revised:
2013-12-20Online:
2014-02-08Published:
2014-01-26Contact:
Yu Liang E-mail:yuliang818@126.comLi Ruijian, Yu Liang. Clinical research for intramedullary spinal cord metastases[J]. Journal of International Oncology, 2014, 41(2): 124-126.
[1] Kalayci M, Caˇgavi F, Gül S, et al. Intramedullary spinal cord metastases: diagnosis and treatment—an illustrated review[J]. Acta Neurochir (Wien), 2004, 146(12): 1347-1354. [2] Kalita O. Current insights into surgery for intramedullary spinal cord metastases: a literature review[J]. Int J Surg Oncol, 2011, 2011: 989506. [3] Hrabalek L, Kalita O, Studentova H, et al. Intramedullary spinal cord and cauda equina metastasis of breast carcinoma: case report[J]. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 2010, 154(2): 175177. [4] Sung WS, Sung MJ, Chan JH, et al. Intramedullary spinal cord metastases: a 20year institutional experience with a comprehensive literature review[J]. World Neurosurg, 2013, 79(34): 576584. [5] Rostami R, Safarpour D, Tavassoli FA, et al. Intramedullary metastasis in breast cancer—a comprehensive literature review[J]. J Neurol Sci, 2013, 332(12): 1620. [6] DamHieu P, Seizeur R, Mineo JF, et al. Retrospective study of 19 patients with intramedullary spinal cord metastasis[J]. Clin Neurol Neurosurg, 2009, 111(1): 1017. [7] Lee SS, Kim MK, Sym SJ, et al. Intramedullary spinal cord metastases: a singleinstitution experience[J]. J Neurooncol, 2007, 84(1): 8589. [8] Ishii T, Terao T, Komine K, et al. Intramedullary spinal cord metastases of malignant melanoma: an autopsy case report and review of the literature[J]. Clin Neuropathol, 2010, 29(5): 334340. [9] Veeravagu A, Lieberson RE, Mener A, et al. CyberKnife stereotactic radiosurgery for the treatment of intramedullary spinal cord metastases[J]. J Clin Neurosci, 2012, 19(9): 12731277. [10] Conill C, Marruecos J, Verger E, et al. Clinical outcome in patients with intramedullary spinal cord metastases from lung cancer[J]. Clin Transl Oncol, 2007, 9(3): 172176. [11] Hrabalek L. Intramedullary spinal cord metastases: review of the literature[J]. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 2010, 154(2): 117122. [12] DoDai DD, Brooks MK, Goldkamp A, et al. Magnetic resonance imaging of intramedullary spinal cord lesions: a pictorial review[J]. Curr Probl Diagn Radiol, 2010, 39(4): 160185. [13] Nguyen NC, Sayed MM, Taalab K, et al. Spinal cord metastases from lung cancer: detection with F18 FDG PET/CT[J]. Clin Nucl Med, 2008, 33(5): 356358. [14] Gilardi L, Vassallo S, Colandrea M, et al. Intramedullary spinal cord metastases from breast cancer: detection with (18)FFDG PET/CT[J]. Ecancermedicalscience, 2013, 7: 329. [15] Hashii H, Mizumoto M, Kanemoto A, et al. Radiotherapy for patients with symptomatic intramedullary spinal cord metastasis[J]. J Radiat Res, 2011, 52(5): 641645. [16] Wilson DA, Fusco DJ, Uschold TD, et al. Survival and functional outcome after surgical resection of intramedullary spinal cord metastases[J]. World Neurosurg, 2012, 77(2): 370374. [17] Hoover JM, Krauss WE, Lanzino G. Intradural spinal metastases: a surgical series of 15 patients[J]. Acta Neurochir (Wien), 2012, 154(5): 871877. [18] Belaid I, Jlassi H, Debbiche G, et al. Lung adenocarcinoma with intramedullary spinal cord metastasis: a case report and review of the literature[J]. Rev Pneumol Clin, 2013, 69(3): 149151. [19] Kodama M, Kawaguchi H, Komoto Y, et al. Coexistent intramedullary spinal cord and choroidal metastases in ovarian cancer[J]. J Obstet Gynaecol Res, 2010, 36(1): 199203. [20] Choi HC, Yoon do H, Kim SC, et al. Two separate episodes of intramedullary spinal cord metastasis in a single patient with breast cancer[J]. J Korean Neurosurg Soc, 2010, 48(2): 162165. |
[1] | Qian Xiaotao, Shi Ziyi, Hu Ge, Wu Xiaowei.Efficacy of consolidation chemotherapy after radical radiotherapy and chemotherapy for stage Ⅲ-ⅣA esophageal squamous cell carcinoma: a real-world clinical study[J]. Journal of International Oncology, 2024, 51(6): 326-331. |
[2] | Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer[J]. Journal of International Oncology, 2024, 51(6): 332-337. |
[3] | Zhang Baihong, Yue Hongyun.Advances in anti-tumor drugs with new mechanisms of action[J]. Journal of International Oncology, 2024, 51(6): 354-358. |
[4] | Xu Fenglin, Wu Gang.Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma[J]. Journal of International Oncology, 2024, 51(6): 359-363. |
[5] | Wang Ying, Liu Nan, Guo Bing.Advances of antibody-drug conjugate in the therapy of metastatic breast cancer[J]. Journal of International Oncology, 2024, 51(6): 364-369. |
[6] | Gao Fan, Wang Ping, Du Chao, Chu Yanliu.Research progress on intestinal flora and non-surgical treatment of the colorectal cancer[J]. Journal of International Oncology, 2024, 51(6): 376-381. |
[7] | Fan Zhipeng, Yu Jing, Hu Jing, Liao Zhengkai, Xu Yu, Ouyang Wen, Xie Conghua.Predictive value of changes in inflammatory markers for prognosis in patients with advanced non-small cell lung cancer treated with the first-line immunotherapy plus chemotherapy[J]. Journal of International Oncology, 2024, 51(5): 257-266. |
[8] | Wang Peixin, Zhao Jun, Xu Shihong, Jiang Zhaoyang, Wang Xiaoqiang, Yang Hongjuan.Progress of ferroptosis-related mechanisms in osteosarcoma[J]. Journal of International Oncology, 2024, 51(5): 308-311. |
[9] | Yang Hao, Shi Guidong, Zhang Chengcheng, Zhang Yue, Zhang Liwen, Fu Maoyong.Comparison of efficacy and safety between sintilimab and tislelizumab in neoadjuvant therapy for advanced esophageal squamous cell carcinoma[J]. Journal of International Oncology, 2024, 51(4): 210-216. |
[10] | Sa Qiang, Xu Hangcheng, Wang Jiayu.Advances in immunotherapy for breast cancer[J]. Journal of International Oncology, 2024, 51(4): 227-234. |
[11] | Yang Zhi, Lu Yiqiao, Gu Huayan, Ding Jialing, Guo Guilong.Research progress of tumor microenvironment mediated drug resistance in targeted therapy of breast cancer[J]. Journal of International Oncology, 2024, 51(4): 235-238. |
[12] | Sun Weiwei, Yao Xuemin, Wang Pengjian, Wang Jing, Jia Jinghao.Exploration of prognostic factors and nomogram construction for advanced non-small cell lung cancer treated with immunotherapy based on hematologic indexes[J]. Journal of International Oncology, 2024, 51(3): 143-150. |
[13] | Qian Xiaotao, Shi Ziyi, Hu Ge.A real-world clinical study of immunocheckpoint inhibitor maintenance therapy after radical radiotherapy and chemotherapy in stage Ⅲ-ⅣA esophageal squamous cell carcinoma[J]. Journal of International Oncology, 2024, 51(3): 151-156. |
[14] | Li Shuyue, Ma Chenying, Zhou Juying, Xu Xiaoting, Qin Songbing.Progress of radiotherapy in oligometastatic non-small cell lung cancer[J]. Journal of International Oncology, 2024, 51(3): 170-174. |
[15] | Liu Yulan, Jing Haiyan, Sun Jing, Song Wei, Sha Dan.Advances in predicting efficacy and prognostic markers of immunotherapy for gastric cancer[J]. Journal of International Oncology, 2024, 51(3): 175-180. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||